LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K Filing

Lixte Biotechnology announced its strategic transformation into an AI energy infrastructure equipment and services platform to address growing power demands from AI data centers. The company also appointed Stuart D. Porter, founder of Denham Capital with over $12 billion in invested capital across the energy sector, to its Board of Directors effective May 29, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure A copy of the press release announcing the Company’s strategic transformation and the appointment of Mr, 9.01 Financial Statements and Exhibits (d) Exhibits)

SEC EDGAR ·

Tickers: $LIXT

Read the full article at SEC EDGAR

More Regulatory news